Linaclotide for treating patients with irritable bowel syndrome with predominant constipation: a multicentre study of real-world data in China

INTRODUCTION: Linaclotide, a guanylate cyclase C agonist that improves the symptoms of irritable bowel syndrome with predominant constipation (IBS-C), has been recently approved for IBS-C treatment. This study aimed to report real-world data on linaclotide treatment in China. METHODS: This was a pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lan, Zhang, Weihao, Zhao, Wei, Guo, Shuang, Wang, Yaojun, Lv, Xiaojun, Li, Bing, Wang, Haiping, Xu, Enbin, Li, Quan, Zhu, Qin, Gou, Xiao bo, Zhao, Weidong, Guo, Jianqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058335/
https://www.ncbi.nlm.nih.gov/pubmed/35509427
http://dx.doi.org/10.1177/17562848221092596

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058335/
https://www.ncbi.nlm.nih.gov/pubmed/35509427
http://dx.doi.org/10.1177/17562848221092596

Ejemplares similares